All Stories

  1. Detection of atrial fibrillation via adhesive single-lead ECG vs. Holter monitoring in embolic stroke of undetermined source: the AVANT-GARDE trial
  2. Antiplatelet Therapy for Stroke Prevention in Atherosclerotic Cardiovascular Disease-Naïve People with Cerebral Small-Vessel Disease: A Retrospective Cohort Study
  3. Differential impact of cumulative cerebral small-vessel disease burden on ischemic versus hemorrhagic stroke recurrence in hemorrhage-prone patients
  4. Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trial
  5. Early Onset, High Comorbidity Burden, and Regional Disparities of CADASIL: A Nationwide Cohort Study in South Korea
  6. Atrial Fibrillation Validation Among Patients with Ischemic Stroke: An Electrocardiogram Comparison Between 24 h Holter and Single-Lead Wearable Devices: Rationale and Design of the AVANT-GARDE Trial
  7. Oxiracetam and physical activity in preventing cognitive decline after stroke: A multicenter, randomized controlled trial
  8. Preadmission CHA2DS2-VASc Scores on Diastolic Function and Functional Outcome After Stroke with Nonvalvular Atrial Fibrillation
  9. Janus Kinase Inhibitor: A Possible Cause of Hyperammonemic Encephalopathy?
  10. Acute Basilar Artery Tip Thrombosis Presenting as Basilar-Subclavian Steal Phenomenon on Transcranial Doppler
  11. Hemorrhagic Focus Within the Recent Small Subcortical Infarcts on Long-Term Follow-Up Magnetic Resonance Imaging
  12. Elevated Pulse Pressure and Recurrent Hemorrhagic Stroke Risk in Stroke With Cerebral Microbleeds or Intracerebral Hemorrhage
  13. Association Between Nonaneurysmal Cortical Subarachnoid Hemorrhage and Intracranial Arterial Stenosis
  14. Atherosclerotic Burden and Vascular Risk in Stroke Patients With Atrial Fibrillation
  15. Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia: The Fimasartan-Based Blood Pressure Control after Acute Cerebral Ischemia Study
  16. Occipital Lobe Epilepsy Presenting with Eyelid Blinking Following Cerebral Venous Sinus Stenotic Thrombosis
  17. Cilostazol versus aspirin in ischemic stroke with cerebral microbleeds versus prior intracerebral hemorrhage
  18. Depressive Symptoms in Stroke Patients: Are There Sex Differences?
  19. Concomitant diabetes or hypertension with metabolic syndrome on the extent of intracranial atherosclerotic stenosis
  20. Baseline D-Dimer Levels as a Risk Assessment Biomarker for Recurrent Stroke in Patients with Combined Atrial Fibrillation and Atherosclerosis
  21. White matter hyperintensities and recurrent stroke risk in patients with stroke with small‐vessel disease
  22. Intracranial Venous Reflux Caused by Occlusion of the Brachiocephalic Vein Mimicking Dural Arteriovenous Fistula
  23. Association of Systolic Blood Pressure with Progression of Symptomatic Intracranial Atherosclerotic Stenosis
  24. Post-stroke diastolic blood pressure and risk of recurrent vascular events
  25. Association of Optimal Combination Drug Treatment with Obesity Status among Recent Ischemic Stroke Patients: Results of the Vitamin Intervention for Stroke Prevention (VISP) Trial
  26. Visceral Fat Is an Independent Predictor of Cerebral Microbleeds in Neurologically Healthy People
  27. Relationship of functional disability after a recent stroke with recurrent stroke risk
  28. Neurologic Symptom Severity after a Recent Noncardioembolic Stroke and Recurrent Vascular Risk
  29. New Pooled Cohort Risk equations: Application to a recent stroke patient population
  30. Nontraditional Serum Lipid Variables and Recurrent Stroke Risk
  31. New Pooled Cohort Risk Equations and Presence of Asymptomatic Brain Infarction
  32. Association of intracranial atherosclerotic stenosis with severity of white matter hyperintensities
  33. Does Small Size Vertebral or Vertebrobasilar Artery Matter in Ischemic Stroke?
  34. Association between metabolic syndrome and previous ischemic lesions in patients with intracranial atherosclerotic stroke